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Abstract
Insulin action and glucose disposal are enhanced by exercise, yet the mecha-
nisms involved remain imperfectly understood. While the causes of skeletal
muscle insulin resistance also remain poorly understood, new evidence suggest
excess plasma membrane (PM) cholesterol may contribute by damaging the
cortical filamentous actin (F-actin) structure essential for GLUT4 glucose
transporter redistribution to the PM upon insulin stimulation. Here, we inves-
tigated whether PM cholesterol toxicity was mitigated by exercise. Male
C57BL/6J mice were placed on low-fat (LF, 10% kCal) or high-fat (HF, 45%
kCal) diets for a total of 8 weeks. During the last 3 weeks of this LF/HF diet
intervention, all mice were familiarized with a treadmill for 1 week and then
either sham-exercised (0 m/min, 10% grade, 50 min) or exercised (13.5 m/
min, 10% grade, 50 min) daily for 2 weeks. HF-feeding induced a significant
gain in body mass by 3 weeks. Sham or chronic exercise did not affect food
consumption, water intake, or body mass gain. Prior to sham and chronic
exercise, “pre-intervention” glucose tolerance tests were performed on all ani-
mals and demonstrated that HF-fed mice were glucose intolerant. While sham
exercise did not affect glucose tolerance in the LF or HF mice, exercised mice
showed an improvement in glucose tolerance. Muscle from sham-exercised
HF-fed mice showed a significant increase in PM cholesterol, loss of cortical
F-actin, and decrease in insulin-stimulated glucose transport compared to
sham-exercised LF-fed mice. These HF-fed skeletal muscle membrane/
cytoskeletal abnormalities and insulin resistance were improved in exercised
mice. These data reveal a new therapeutic aspect of exercise being regulation
of skeletal muscle PM cholesterol homeostasis. Further studies on this
mechanism of insulin resistance and the benefits of exercise on its prevention
are needed.
Introduction
Insulin resistance starts years before type 2 diabetes
(T2D) diagnosis, even before recognition of prediabetes
(Mason et al. 2007; Tabak et al. 2009). From a public
health standpoint, physical activity is central to both the
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prevention and treatment of T2D, yet the exact mecha-
nisms for this effect remain imperfectly understood. For
some time it has been known that muscle contractions
stimulate GLUT4-mediated glucose uptake independent
of insulin (Constable et al. 1988; Douen et al. 1990;
Ryder et al. 2001). Advances in our understanding of the
contraction-stimulated signal to GLUT4 has been made
through the years and presented in several recent reviews
(Cartee 2015a; Rohling et al. 2016; Sylow et al. 2017).
More pertinent to studies conducted in this report is that
exercise increases skeletal muscle insulin sensitivity by
poorly understood local changes in insulin action and
GLUT4 functionality (Holloszy 2005; Maarbjerg et al.
2011; Cartee 2015b). For example, animal and human
studies report that exercise increases insulin sensitivity
without a simultaneous increase in proximal insulin sig-
naling (Goodyear et al. 1995; Wojtaszewski et al. 1997,
2000; Funai et al. 2009). While a surprising finding that
enhanced proximal insulin signaling is not a feature of
the exercise effect, this corresponds well with an emerging
appreciation that defects in proximal insulin signaling
may not represent a major node of insulin resistance
(Hoehn et al. 2008; Hoy et al. 2009). As enhanced skeletal
muscle insulin-stimulated glucose transport following
exercise results from, at least in part, increased sarcolem-
mal GLUT4 content (Hansen et al. 1998; Geiger et al.
2006), a defect in GLUT4 trafficking not coupled to prox-
imal insulin signaling must be alleviated by exercise.
Importantly, this increase in insulin-stimulated GLUT4
translocation after exercise is not dependent upon ele-
vated muscle total GLUT4 content (Fisher et al. 2002).
Notwithstanding, however, with multiple bouts of exercise
muscle GLUT4 expression and content does increase and
represents a key beneficial adaptation of chronic exercise
along with increased capillary density, increased expres-
sion of other proteins regulating metabolism, and
increased abundance of oxidative muscle fibers(Richter
and Hargreaves 2013; Sylow et al. 2017). What remains
elusive, however, are the mechanisms involved in the
enhancement of insulin-stimulated GLUT4-mediated glu-
cose transport postexercise. Several possibilities exist
including a residual effect of contraction-stimulated glu-
cose transport. However, this insulin-mimetic action of
exercise is mostly reversed by ~2-3 h postexercise,
whereas enhanced muscle insulin sensitivity, detectable at
~1-4 h postexercise, can persist for up to 24-48 h (Cartee
2015b). While enhanced microvascular perfusion could
also contribute, several studies have reported that an
intact systemic circulation is not necessary for developing
increased insulin sensitivity after exercise (Gulve et al.
1990; Funai et al. 2010; Sjoberg et al. 2017).
Novel translational findings from our laboratory now
afford a fresh perspective on how caloric excess may
contribute to the deterioration of insulin action, perhaps
early in the development of insulin resistance. We have
found that increased hexosamine biosynthesis pathway
(HBP) activity in fat/muscle cells increases O-linked
N-acetylglucosamine modification of the transcription
factor Sp1, leading to transcriptional activation of
HMG-CoA reductase, the rate-limiting enzyme in choles-
terol biosynthesis (Bhonagiri et al. 2011; Habegger et al.
2012a; Penque et al. 2013). This HBP-induced choles-
terolgenic transcriptional response increases cholesterol
in the plasma membrane (PM), while reducing cortical
filamentous actin (F-actin) that is essential for insulin-
stimulated GLUT4-mediated glucose transport (Tsakiridis
et al. 1994; Brozinick et al. 2004; Torok et al. 2004;
Bhonagiri et al. 2011; Habegger et al. 2012a; Penque
et al. 2013). Strikingly, inhibition of the HBP or Sp1
binding to DNA blocked both PM cholesterol accumula-
tion, F-actin loss, and GLUT4/glucose transport dysregu-
lation (Bhonagiri et al. 2011; Habegger et al. 2012a;
Penque et al. 2013). We have also shown that insulin-
stimulated glucose disposal in mice, rats, swine, and
humans is inversely related to PM cholesterol content
(Habegger et al. 2012a) and that normalization of PM
cholesterol restores insulin responsivity (Bhonagiri et al.
2011; Habegger et al. 2012a,b). In support of PM choles-
terol toxicity representing an early etiological factor of
insulin resistance, key insulin signaling events (e.g., IR?
IRS?PI3K?Akt2?AS160) are sufficiently intact in sev-
eral in vitro and in vivo models of HBP-induced insulin
resistance (Kralik et al. 2002; Chen et al. 2003; Habegger
et al. 2012a).
This PM cholesterol accumulation and insulin resis-
tance model is in accord with recent gene expression net-
work studies (Ding et al. 2015; Fall et al. 2015). In these
large data sets, alterations in a network of coexpressed
cholesterol metabolism genes were associated with T2D
susceptibility. This network included genes related to
cholesterol uptake, synthesis, and efflux - producing a
molecular profile expected to increase intracellular choles-
terol. Given the lack of clarity on how skeletal muscle
insulin sensitivity is improved after exercise, we tested the
possibility that exercise improves membrane cholesterol
and actin cytoskeletal aspects of GLUT4 regulation. Data
presented support this notion.
Materials and Methods
Mice
Male C57BL/6J mice were obtained at 4 weeks of age
from Jackson Laboratory, Bar Harbor, ME. All mice were
singly housed in conventional cages and maintained on a
12-h light/dark cycle. Body weight and food intake were
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recorded weekly. All animal protocols were approved by
the IUSM Institutional Animal Care and Use Committee.
Diet
Upon arrival to our facility, all mice had free access to
water and standard laboratory chow for 2 wks. Following
this 2-week acclimation period, all mice received a low-fat
(LF) diet containing 20% kcal from protein, 70% kcal
from carbohydrates, and 10% kcal from fat (D01030107,
Research Diets Inc., New Brunswick, NJ) for 3 wks to
adapt to the modified diet. This LF, as well as the high-
fat (HF), diet represented modified forms of the standard
LF (D12450B) and HF (D12451) diets from Research
Diets Inc., with adaptations regarding type of fat (palm
oil instead of lard) and carbohydrates, to better mimic
the fatty acid (FA)/carbohydrate composition of the aver-
age human diet in Western societies (de Wit et al. 2008).
Following this 5-wk acclimation/diet adaptation period,
mice were either left on the LF diet or switched to the
HF diet containing 20% kcal from protein, 35% kcal
from carbohydrates, and 45% kcal from fat (D01030108)
for 8 wks. This HF diet mimics the percent of saturated
to monounsaturated to polyunsaturated FAs (40:40:20).
Exercise
During the last 3 weeks of the LF/HF diet intervention,
all mice were familiarized with a treadmill for 1 week and
then either sham-exercised (0 m/min, 10% grade,
50 min) or exercised (13.5 m/min, 10% grade, 50 min)
daily for 2 weeks. Throughout the 1-wk familiarization
and 2-wk exercise intervention, mice were maintained on
either their LF- or HF-diets. Following the last sham-exer-
cise or exercise session, mice were fasted for 5-6 h before
analyses, a time when elevated insulin-independent glu-
cose uptake during exercise is mostly reversed; that is,
~2-3 h postexercise (Cartee 2015b).
Glucose tolerance test
For the intraperitoneal glucose tolerance test, 5-6 h fasted
mice were administered glucose (2 g/kg mass i.p.). Tail
vein blood glucose was measured at times indicated with
an AlphaTRAK blood glucose meter (Abbott Laboratories,
Inc. Alameda, CA).
Actin analyses
A thin slice of mixed hindlimb skeletal muscle was
labeled, mounted in Vectashield, and analyzed via confo-
cal microscopy (LSM 510 NLO; Zeiss, Thornwood, NY)
as previously described (Brozinick et al. 2004). Prior to
imaging, all samples were de-identified to ensure an
objective analysis. All images were taken in the same focal
plane of the section and under identical microscopic
parameters. Images shown are representative of 5-7 fields
from each sample.
Cholesterol analyses
Mixed hindlimb skeletal muscle crude PM pellets
obtained from differential centrifugation were resus-
pended in 0.2 ml of HES buffer, and cholesterol content
was assayed using the Amplex Red Cholesterol Assay Kit
(Molecular Probes), as previously described (Bhonagiri
et al. 2011).
Measurement of glucose transport
Mice in the postprandial state were rapidly euthanized by
cervical dislocation and extensor digitalis longus (EDL)
muscles were dissected out, blotted on gauze, and trans-
ferred to 25 ml Erlenmeyer flasks containing 2 ml of
Krebs-Henseleit buffer (KHB) with 0.1% bovine serum
albumin (BSA), 32 mM mannitol, and 8 mM glucose.
The flasks were incubated in a shaking water bath main-
tained at 30°C for 1 h, and were continually gassed with
95% CO2. Muscles were initially incubated for 60 min
prior to incubation under basal conditions or stimulation
with submaximal insulin (60 lU/ml). The muscles were
then transferred to flasks containing 2 ml of KHB with
0.1% BSA, 40 mM mannitol, 2 mM pyruvate and the
same additions as in the previous incubation. Glucose
transport activity was measured using 2-deoxyglucose
(2-DG) as described in detail previously (Habegger et al.
2012b).
Statistical analyses
Values presented are means SEM. The significance of
differences between means was evaluated by ANOVA.
Where a difference was indicated by ANOVA, a New-
man-Keuls post hoc test was conducted to compare dif-
ferences between groups. Statistical comparisons of the
change of pre- and post-exercise glucose tolerance were
performed by a paired, two-tailed Student’s t test. Area
under the curve (AUC) with respect to the increase was
calculated for all GTT measures. GraphPad Prism 7 soft-
ware was used for all analyses. P<0.05 was considered
significant.
Results
Mice fed a HF diet had a significant gain in body mass
by 3 wks (Fig. 1A). Sham (SH) or chronic exercise (EX)
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did not affect food consumption (Fig 1A, inset) or water
intake (data not shown) or body mass gain (Fig. 1A).
Prior to sham and exercise, “pre-intervention” GTTs were
performed on all mice and demonstrated that HF-fed
mice were glucose intolerant (Fig. 1B).
While sham exercise did not affect glucose tolerance in
the LF- or HF-fed mice (Figs. 2A and B, compare pre-
and post-tracings and solid and patterned bars), HF-fed
exercised mice showed an improvement in glucose toler-
ance (Fig. 2C, compare pre- and post-tracings and solid
and patterned bars).
Consistent with this, muscle from sham-exercised
HF-fed mice showed a significant decrease in insulin-
stimulated glucose transport compared to sham-exercised
LF-fed mice (Fig. 3A, compare white and black bars).
This HF-fed-induced decrease in insulin-stimulated glu-
cose transport was significantly improved, but not fully
restored, in muscles from exercised mice (Fig. 3A, gray
bars).
Mixed hindlimb muscle from the sham-exercised
HF-fed mice showed a reciprocal increase in PM choles-
terol (Fig. 3B, compare white and black bars) and
decrease in cortical F-actin (Figs. 3C and 3D, compare
top and middle panels and white and black bars),
compared to that measured in muscles from the sham-
exercised LF-fed mice.
Exercise completely normalized the excess PM choles-
terol measured in skeletal muscle from HF-fed mice
(Fig. 3B, gray bars). Similar to the measured partial
improvement in insulin-stimulated glucose transport, the
HF-fed-induced decrease in cortical F-actin was signifi-
cantly improved, yet not fully, in muscles from exercised
mice (Figs. 3C and D, bottom panel and gray bar).
Discussion
In this work, we investigated whether excess PM choles-
terol, which compromises cortical actin filaments essential
for insulin-stimulated glucose transport, is improved by
exercise. We showed that muscle from sham-exercised
HF-fed mice had increased PM cholesterol, decreased cor-
tical F-actin, and impaired insulin-stimulated glucose
transport compared to sham-exercised LF-fed mice. These
observed membrane and cytoskeletal changes are recog-
nized abnormalities that contribute to skeletal muscle
insulin resistance in glucose intolerant mice, rats, swine,
and humans (Habegger et al. 2012a,b; Llanos et al. 2015).
Both ex vivo and in vivo exposure of insulin-resistant
skeletal muscle to methyl-b-cyclodextrin (MbCD) has
been documented to normalize excess PM cholesterol
content and improve skeletal muscle insulin sensitivity
(Habegger et al. 2012b; Llanos et al. 2015). Here we simi-
larly found that these HF-fed skeletal muscle membrane/
cytoskeletal abnormalities and insulin resistance were
improved in exercised mice, and that these exercised mice
showed improved glucose tolerance. While it is possible
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Figure 1. (A) Body mass during the 5-week acclimation period
(weeks -5 to 0), 8-week low-fat (LF) or high-fat (HF) diet (weeks
0–8), and the 2-week sham (SH) or exercise (EX) interventions
(weeks 6–8). The inset shows food intake during the 8-week diet
and 2-week SH/EX intervention. Body mass and food intake values
are means  SEM from 17 LF + SH, 18 HF + SH, and 18 HF + EX
mice. (B) Pre-SH/EX intervention glucose tolerance was determined
at 5 weeks. Blood glucose was measured before and after injection
of 2 g glucose/kg body mass. Glucose values are means  SEM
from 17 LF + SH, 17 HF + SH, and 17 HF + EX mice. Two-way
ANOVA (A) and one-way ANOVA (B, inset) post hoc analysis
statistics are indicated with *P < 0.05; **P < 0.01; ***P < 0.001;
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that the beneficial effects we measured could be attributed
to a lingering insulin-mimetic action of exercise, studies
suggest that acute exercise-stimulated glucose transport is
mostly reversed by ~2-3 h postexercise (Cartee 2015b).
Regardless, our studies reveal that an aspect of skeletal
muscle insulin resistance improved by exercise, whether
acute, chronic, or a combination of both, is membrane/0 30 60 90 120
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Figure 3. (A) Paired extensor digitalis longus muscles were
subjected to basal and insulin-stimulated 2-DG uptake
measurements as described in Methods. Uptake values are
means  SEM from 4 LF + SH, 4 HF + SH, and 5 HF + EX
muscles. (B, C, D) Mix hindlimb skeletal muscle were subjected to
fractionation for membrane cholesterol determination (B) or were
labeled with antibodies against F-actin and imaged by confocal
microscopy (C) and images were digitally quantitated using
MetaMorph software (D) as described in Methods. Cholesterol
values are means  SEM from 12 LF + SH, 12 HF + SH, and 12
HF + EX muscles and F-actin values are means SEM from 3 to 5
images of 5 LF + SH, 5 HF + SH, and 5 HF + EX muscles. One-way
ANOVA post hoc analysis statistics are indicated with *P < 0.05 (vs.
LF + SH +Insulin); #P < 0.05 (vs. HF + SH + Insulin).
Figure 2. Pre- and post-SH/EX intervention glucose tolerance was
determined at 5- or 8- weeks, respectively, for LF- (A), or HF- (B,C)
fed mice. Blood glucose was measured before and after injection of
2 g glucose/kg body mass. All values are means  SEM from 17
LF + SH, 17 HF + SH, and 17 HF + EX mice. AUC differences were
determined using a paired two-tailed Student’s t test and statistic
indicated with nsP > 0.05; *P < 0.05. Solid and hatched bars
represent pre- and post-SH/EX interventions, respectively. Note
some error bars are shorter than the symbols.
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cytoskeletal defects that impair GLUT4 regulation by
insulin. How long membrane cholesterol and/or actin fila-
ment structure remains normalized after exercise is not
known. Moreover, whether the same benefit could be
measured after a single bout of exercise is not known.
In a previous study, we examined the effect of
increased AMP-activated protein kinase (AMPK) activity
on countering PM cholesterol accumulation and insulin
resistance in L6 myotubes (Habegger et al. 2012b). An
important aspect of AMPK functionality is its inactivation
of energy-consuming pathways such as fatty acid and
cholesterol synthesis. We found that cells cultured in a
hyperinsulinemic milieu, resembling conditions in vivo
that promote the progression/worsening of insulin resis-
tance, displayed an increase in membrane cholesterol.
This occurred concomitantly with a loss of cortical
F-actin and defects in GLUT4 regulation by insulin. These
derangements were prevented by AMPK stimulation.
Given the well-established effect of exercise on increasing
AMPK activity, the data presented herein are consistent
with the beneficial membrane/cytoskeletal effects of exer-
cise on insulin sensitivity resulting from increased AMPK
activity. We did not measure AMPK activity, as several
studies have reported that AMPK activation is reversed
within 30-60 min postexercise/contraction (Rasmussen
et al. 1998; Vendelbo et al. 2014). As 3-hydroxy-
3-methylglutaryl coenzyme A reductase (HMGR), a
rate-limiting enzyme in cholesterol synthesis, is phospho-
rylated and inhibited by AMPK (Clarke and Hardie 1990;
Sato et al. 1993), the transient exercise-enhanced AMPK
activity is potentially important for mitigating PM choles-
terol accumulation/toxicity. Also, multiple lines of evi-
dence indicate that AMPK activation suppresses the
activity of sterol-regulatory element-binding proteins
(SREBPs) that are major transcription factors activating
the expression of genes involved in biosynthesis of choles-
terol, fatty acids, and triglycerides (Zhou et al. 2001; Yang
et al. 2008). As such, suppression of both HMGR and
SREBPs by AMPK would be predicted to lower mem-
brane cholesterol and enhance GLUT4 regulation. In sup-
port of this possibility, inhibition of SREBP was found to
ameliorate diet-induced cholesterol/lipid tissue accumula-
tion and insulin resistance (Tang et al. 2011).
As to why lipid lowering drugs, such as statins, are
associated with increased incidence of new on-set diabetes
remains imperfectly understood, yet mechanisms have
been proposed and discussed in the literature (Brault
et al. 2014; Robinson 2015). Interestingly, nearly two dec-
ades of randomized, control trials and meta-analyses have
revealed that the risk is not the same among statins with
atorvastatin, simvastatin, and rosuvastatin being the most
diabetogenic, lovastatin and fluvastatin having an inter-
mediate risk, and pravastatin and pitavastatin having the
lowest diabetogenicity (Millan Nunez-Cortes et al. 2016;
Thakker et al. 2016). In fact, basic and clinical data sug-
gest that these least diabetogenic statins, especially
pitavastatin, may even exhibit a positive effect on glucose
metabolism(Teramoto 2011; Daido et al. 2014; Huang
et al. 2016). Intricately layered in our full understanding
of why and how statins negatively or positively impact
glycemic health is an array of factors including patient
characteristics and integrative control mechanisms of
cholesterol regulation. Of note in regards to skeletal mus-
cle insulin sensitivity, is that similar to the upregulation
of low-density lipoprotein (LDL) receptors (LDLRs) that
occurs in liver with cholesterol biosynthesis inhibition,
muscle LDLRs and LDL cholesterol (LDL-C) uptake are
increased in mice treated with high doses of simvastatin
(Yokoyama et al. 2007). It has also been found that skele-
tal muscle LDL-C uptake is increased in statin-treated
mice overexpressing lipoprotein lipase (LPL) in skeletal
muscle (Yokoyama et al. 2007). These data suggest that
LPL [the primary enzyme for intravascular hydrolysis of
triglyceride (TG)], could also be an important mediator
of skeletal muscle cholesterol uptake. Notably, statins
increase LPL serum mass and activity in T2D (Endo et al.
2004). Perhaps these findings offer some explanation as
to why some statins increase, albeit modestly, the risk of
T2D(Thakker et al. 2016). Together, these studies demon-
strate evidence implicating a change in cholesterol meta-
bolism, favoring intracellular cholesterol accumulation, as
a potential risk factor for T2D. Also of interest are data
suggesting statin diabetogenicity may be more coupled to
defects in pancreatic b-cell insulin secretory and not
peripheral insulin action(Brault et al. 2014; Robinson
2015; Salunkhe et al. 2016). In accordance, Salunkhe et al.
recently found dual effects on glucose homeostasis by
rosuvastatin where insulin sensitivity was improved, but
b-cell function was impaired in high-fat fed mice (Salu-
nkhe et al. 2016).
Previously we demonstrated that increased hexosamine
biosynthesis pathway (HBP) activity resulting from dia-
betic culturing conditions (e.g., hyperglycemia, hyperinsu-
linemia, and hyperlipidemia) increase membrane
cholesterol in 3T3-L1 adipocytes and L6 myotubes via
engagement of a cholesterolgenic program (Bhonagiri
et al. 2011; Habegger et al. 2012a; Penque et al. 2013). In
line with increased HBP activity transcriptionally provok-
ing a membrane cholesterol-based insulin-resistant state,
we found that HBP inhibition attenuated the transcrip-
tion and expression of genes involved in cholesterol syn-
thesis (e.g., Hmgcr) and prevented membrane cholesterol
accumulation, F-actin loss, and GLUT4/glucose transport
dysfunction (Bhonagiri et al. 2011; Habegger et al. 2012a;
Penque et al. 2013). These data support the concept that
the diabetic milieu known to accelerate diabetes
2017 | Vol. 5 | Iss. 16 | e13363
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progression is associated with increased de novo choles-
terol synthesis. The resultant gain in skeletal muscle
membrane cholesterol compromises cortical F-actin struc-
ture that is essential for insulin-regulated GLUT4 translo-
cation and glucose transport. This PM cholesterol
accumulation and insulin resistance model is in accord
with recent gene expression network studies (Ding et al.
2015; Fall et al. 2015). In these large data sets, alterations
in a network of coexpressed cholesterol metabolism genes
were associated with T2D susceptibility. This network
included genes related to cholesterol uptake, synthesis,
and efflux - producing a molecular profile expected to
increase intracellular cholesterol. Data presented herein
suggest for the first time that exercise may be an effective
countermeasure of membrane cholesterol accumulation/
toxicity.
Our analyses provide a novel new beneficial aspect of
exercise, which could explain, at least in part, how exer-
cise improves skeletal muscle insulin sensitivity. In addi-
tion to this favorable effect of exercise on mitigating PM
cholesterol accumulation/toxicity, other processes under-
lying increased insulin sensitivity postexercise could exist.
For example, several studies raise the possibility that
lower glycogen and/or sustained insulin-independent
AS160 phosphorylation postexercise might sensitize skele-
tal muscle to insulin (reviewed in (Cartee 2015b)). While
we did not measure glycogen or AS160 phosphorylation,
the importance of decreased glycogen and/or increased
AS160 activity toward enhanced insulin-sensitivity is
unclear (Cartee 2015b). Ex vivo and in situ analyses
demonstrate that glycogen reduction and enhanced insu-
lin sensitivity are not correlated (Cartee 2015b). However,
high-carbohydrate diet postexercise speeds glycogen
resynthesis concomitant with reversal of increased insu-
lin-stimulated glucose uptake (Cartee 2015b). An alterna-
tive explanation could be an increased HBP
cholesterolgenic response, not glycogen resynthesis, con-
tributes to the loss of insulin sensitivity. Unlike the dis-
cordant data from in vitro and in vivo analyses where a
role for glycogen is uncoupled and coupled, respectively,
a role for cholesterol and cortical F-actin is significantly
coupled in both in vitro and in vivo analyses (Habegger
et al. 2012a,b). With regard to a beneficial effect of exer-
cise-stimulated AS160 activity being favorable for subse-
quent insulin signal transduction, some aspects of this
possibility remain unclear. For example, we previously
reported that the palmitate-induced decrease in insulin
signaling in L6-myotubes was not corrected by AMPK
stimulation, yet increased PM cholesterol, reduced cortical
F-actin, and defective glucose transport in these cells were
fully corrected (Habegger et al. 2012a). The observation
that insulin-stimulates a fully intact glucose transport
response in cells where insulin signaling remained
compromised by palmitate treatment is consistent with
findings by Hoehn et al. showing that only a small per-
centage of total Akt activation is required for a full insu-
lin-stimulated glucose transport response (Hoehn et al.
2008). Together these findings suggest that an early com-
ponent of insulin resistance may be membrane/cytoskele-
tal abnormalities that exercise, possibly via AMPK
stimulation, improves. While there may exist some defi-
ciency in insulin signaling, it is of interest that the capac-
ity of the system may be such to still adequately
transduce a sufficient signal to GLUT4 and elicit a normal
redistribution of the transporter to a healthy cholesterol
and cortical F-actin cell surface environment. It is impor-
tant to note, however, while we see normal insulin-stimu-
lated Akt2 and AS160 phosphorylation in cells displaying
PM cholesterol accumulation and F-actin loss, it is not
known whether these membrane/cytoskeletal derange-
ments could alter AS160 phosphorylation after exercise.
Thus, an interesting possibility is that exercise
may improve AS160 phosphorylation via mitigating
membrane/cytoskeletal-mediated suppression of AS160
phosphorylation.
In light of the recognized benefits of physical activity on
reducing the incidence of T2D development in people with
glucose intolerance, further study of how different types of
exercise modes influence membrane and cytoskeletal
aspects of insulin action are warranted. Interestingly, our
exercise regime that improved insulin action was not
accompanied by a concomitant loss of body mass. This
observation may suggest that the effectiveness of lifestyle
interventions to reduce the incidence of diabetes may not
require interventions to achieve weight loss.
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